Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Page 1
The Risk of Bone Fractures in Post-Poliomyelitis Patients Transitioning to Middle Adulthood.
Sherf RM, Cantrell D, Or K, Marcus E, Shapira A, Benbassat C, Ish-Shalom S, Koren R. Sherf RM, et al. Among authors: ish shalom s. Endocr Pract. 2020 Nov;26(11):1277-1285. doi: 10.4158/EP-2020-0102. Endocr Pract. 2020. PMID: 33471657
METHODS: A cross-sectional retrospective data analysis from medical records of 204 PPS patients regarding their clinical characteristics and long-term outcome, with emphasis on bone metabolism status. RESULTS: Our cohort included 53% women; mean age was 65 years at study e …
METHODS: A cross-sectional retrospective data analysis from medical records of 204 PPS patients regarding their clinical characteristics and …
Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data.
Shalev V, Sharman Moser S, Goldshtein I, Yu J, Weil C, Ish-Shalom S, Rouach V, Chodick G. Shalev V, et al. Among authors: ish shalom s. Ann Pharmacother. 2017 Sep;51(9):757-767. doi: 10.1177/1060028017710482. Epub 2017 May 23. Ann Pharmacother. 2017. PMID: 28535690
However, concerns have been raised regarding the effectiveness of bisphosphonates in reducing hip fracture risk after long-term use, particularly among patients with suboptimal adherence. ...CONCLUSIONS: Adherence with bisphosphonates among osteoporotic patients is associa …
However, concerns have been raised regarding the effectiveness of bisphosphonates in reducing hip fracture risk after long-term use, …
Differences in homeostatic model assessment (HOMA) values and insulin levels after vitamin D supplementation in healthy men: a double-blind randomized controlled trial.
Tepper S, Shahar DR, Geva D, Ish-Shalom S. Tepper S, et al. Among authors: ish shalom s. Diabetes Obes Metab. 2016 Jun;18(6):633-7. doi: 10.1111/dom.12650. Epub 2016 Mar 31. Diabetes Obes Metab. 2016. PMID: 26890031 Clinical Trial.
Vitamin D supplementation administered for 12 months in healthy men maintained insulin levels and HOMA-IR values relative to the increase in the control group. Further studies are needed to establish the long-term effect of vitamin D supplementation on the risk of diabetes …
Vitamin D supplementation administered for 12 months in healthy men maintained insulin levels and HOMA-IR values relative to the increase in …
Cost and Consequences of Nonadherence With Oral Bisphosphonate Therapy: Findings From a Real-World Data Analysis.
Sharman Moser S, Yu J, Goldshtein I, Ish-Shalom S, Rouach V, Shalev V, Modi A, Chodick G. Sharman Moser S, et al. Among authors: ish shalom s. Ann Pharmacother. 2016 Apr;50(4):262-9. doi: 10.1177/1060028015626935. Epub 2016 Jan 18. Ann Pharmacother. 2016. PMID: 26783359
CONCLUSIONS: In patients 75 years and older, nonadherence with oral bisphosphonates can be associated with significantly greater short-term risk of osteoporotic fractures and higher utilization of health care services....
CONCLUSIONS: In patients 75 years and older, nonadherence with oral bisphosphonates can be associated with significantly greater short-te …
Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.
Devogelaer JP, Sambrook P, Reid DM, Goemaere S, Ish-Shalom S, Collette J, Su G, Bucci-Rechtweg C, Papanastasiou P, Reginster JY. Devogelaer JP, et al. Among authors: ish shalom s. Rheumatology (Oxford). 2013 Jun;52(6):1058-69. doi: 10.1093/rheumatology/kes410. Epub 2013 Jan 30. Rheumatology (Oxford). 2013. PMID: 23365149 Clinical Trial.
OBJECTIVE: Long-term glucocorticoid use is accompanied by rapid bone loss; however, early treatment with bisphosphonates prevents bone loss and reduces fracture risk. ...
OBJECTIVE: Long-term glucocorticoid use is accompanied by rapid bone loss; however, early treatment with bisphosphonates prevents bon …
Two years adherence to anti-osteoporotic medications in postmenopausal Israeli women.
Segal E, Ish-Shalom S. Segal E, et al. Among authors: ish shalom s. Arch Gerontol Geriatr. 2009 Nov-Dec;49(3):360-3. doi: 10.1016/j.archger.2008.11.016. Epub 2009 Jan 14. Arch Gerontol Geriatr. 2009. PMID: 19147238
Treatment of postmenopausal osteoporosis comprises a major public health challenge requiring adherence to long-term therapy in order to prevent fractures and disability. The aim of this work was to assess long-term adherence to anti-osteoporosis treatments in Israel …
Treatment of postmenopausal osteoporosis comprises a major public health challenge requiring adherence to long-term therapy in order …
Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients.
Ish-Shalom S, Segal E, Salganik T, Raz B, Bromberg IL, Vieth R. Ish-Shalom S, et al. J Clin Endocrinol Metab. 2008 Sep;93(9):3430-5. doi: 10.1210/jc.2008-0241. Epub 2008 Jun 10. J Clin Endocrinol Metab. 2008. PMID: 18544622 Clinical Trial.
Therefore, the choice of dose frequency can be based on whichever approach will optimize an individual's adherence with long-term vitamin D supplementation....
Therefore, the choice of dose frequency can be based on whichever approach will optimize an individual's adherence with long-term vit …
Sialochemical and oxidative analyses in radioactive I131-treated patients with thyroid carcinoma.
Ish-Shalom S, Durleshter L, Segal E, Nagler RM. Ish-Shalom S, et al. Eur J Endocrinol. 2008 May;158(5):677-81. doi: 10.1530/EJE-07-0634. Eur J Endocrinol. 2008. PMID: 18426826 Clinical Trial.
Although lower dosage is now widely accepted, I131 may still be the source of salivary damage over the long-term and subsequent harmful effects on both the oral cavity and the gastrointestinal tract, into which the saliva is swallowed. ...
Although lower dosage is now widely accepted, I131 may still be the source of salivary damage over the long-term and subsequent harmf …
Treatment preference and tolerability with alendronate once weekly over a 3-month period: an Israeli multi-center study.
Weiss M, Vered I, Foldes AJ, Cohen YC, Shamir-Elron Y, Ish-Shalom S; Israeli Alendronate OW Study Group. Weiss M, et al. Among authors: ish shalom s. Aging Clin Exp Res. 2005 Apr;17(2):143-9. doi: 10.1007/BF03324587. Aging Clin Exp Res. 2005. PMID: 15977463
BACKGROUND AND AIMS: Osteoporosis is a chronic condition requiring long-term treatment, for which compliance is not easy to achieve. 70 mg of alendronate once weekly (alendronate OW) provides equivalent efficacy to treatment with 10 mg of alendronate once a day (alendronat …
BACKGROUND AND AIMS: Osteoporosis is a chronic condition requiring long-term treatment, for which compliance is not easy to achieve. …
Sustained effect of short-term calcium supplementation on bone mass in adolescent girls with low calcium intake.
Dodiuk-Gad RP, Rozen GS, Rennert G, Rennert HS, Ish-Shalom S. Dodiuk-Gad RP, et al. Among authors: ish shalom s. Am J Clin Nutr. 2005 Jan;81(1):168-74. doi: 10.1093/ajcn/81.1.168. Am J Clin Nutr. 2005. PMID: 15640477 Free article.
BACKGROUND: The effect of short-term calcium supplementation on peak bone mass in adolescent girls is not completely defined. ...
BACKGROUND: The effect of short-term calcium supplementation on peak bone mass in adolescent girls is not completely defined. ...
14 results